KLK3 and prostate carcinoma: As previous studies stated (1–3), PSA screening have been adopted since 1990's in quite a few countries in America, Europe, and Australia, which detects more prostate cancer in localized stage, resulting in the downward of advanced stage of prostate cancer, and the five-year survival rates of prostate cancer in these countries have been approaching 100% (57).